🔬🩸 We’ve recruited the first patient globally for a trial exploring treatments for a rare type of #BloodCancer.
The trial is studying those with a medical condition known as #MyelodysplasticSyndromes.
đź”— Find out more: tinyurl.com/2tzpmkjr
@kingscollegenhs.bsky.social